<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/Newsletter/style.css"/>
<title>Institutional investors in Edwards Lifesciences Corporation (NYSE:EW) see US$1.5b decrease in market cap last week, although long-term gains have benefitted them. â€” Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/Newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Institutional investors in Edwards Lifesciences Corporation (NYSE:EW) see US$1.5b decrease in market cap last week, although long-term gains have benefitted them.</h2>
    <div class="badge">2025-09-15T12:30:30+00:00</div>
    <ul>
      <li>Though their holding amounts to less than 1%, we can see that board members collectively own US$418m worth of shares (at current prices).</li>
<li>is currently the largest shareholder, with 12% of shares outstanding.</li>
<li>Still, the 12% one-year gains may have helped mitigate their overall losses.</li>
<li>And the group that holds the biggest piece of the pie are institutions with 88% ownership.</li>
<li>In comparison, the second and third largest shareholders hold about 9.5% and 4.4% of the stock.</li>
<li>Our data suggests that insiders own under 1% of Edwards Lifesciences Corporation in their own names.</li>
<li>Institutional investors own over 50% of the company, so together than can probably strongly influence board decisions.</li>
    </ul>
    <p>
      <a class="btn" href="https://x.com/intent/tweet?text=Institutional%20investors%20in%20Edwards%20Lifesciences%20Corporation%20%28NYSE%3AEW%29%20see%20US%241.5b%20decrease%20in%20market%20cap%20last%20week%2C%20although%20long-term%20gains%20have%20benefitted%20them.%0A%E2%80%A2%20Though%20their%20holding%20amounts%20to%20less%20than%201%25%2C%20we%20can%20see%20that%20board%20members%20collectively%20own%20US%24418m%20worth%20of%20shares%20%28at%20current%20prices%29.%0A%E2%80%A2%20is%20currently%20the%20largest%20shareholder%2C%20with%2012%25%20of%20shares%20outstanding.%0A%E2%80%A2%20Still%2C%20the%2012%25%20one-year%20gains%20may%20have%20helped%20mitigate%20their%20overall%20losses.%0A%E2%80%A2%20And%20the%20group%20that%20holds%20the%20biggest%20piece%20of%20the%20pie%20are%20institutions%20with%2088%25%20ownership.%0A%E2%80%A2%20In%20comparison%2C%20the%20second%20and%20third%20largest%20shareholders%20hold%20about%209.5%25%20and%204.4%25%20of%20the%20stock.%0A%E2%80%A2%20Our%20data%20suggests%20that%20insiders%20own%20under%201%25%20of%20Edwards%20Lifesciences%20Corporation%20in%20their%20own%20names.%0A%E2%80%A2%20Institutional%20investors%20own%20over%2050%25%20of%20the%20company%2C%20so%20together%20than%20can%20probably%20strongly%20influence%20board%20decisions.&url=https%3A%2F%2Fsuavir600.github.io%2FNewsletter%2Farticles%2Finstitutional-investors-in-edwards-lifesciences-corporation-nyse-ew-see-us-1-5b%2F" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a class="btn" href="https://finance.yahoo.com/news/institutional-investors-edwards-lifesciences-corporation-123030109.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>